Electrocore SEC Filings

electroCore (ECOR) filed a Form 4 for its CFO. On 11/12/2025, the executive sold 2,166 shares of Common Stock at a weighted average price of $6.18, with trade prices ranging from $6.0602 to $6.31. Following the sale, the reporting person beneficially owns 23,667 shares.

This balance includes shares issuable under previously granted RSUs: 10,000 scheduled to vest on January 15, 2026 (3,333), January 15, 2027 (3,333), and January 15, 2028 (3,334); and 13,667 of which 3,000 have vested and 10,667 are set to vest on January 12, 2026 (5,333) and January 12, 2027 (5,334), subject to service and change-in-control provisions.

electroCore (ECOR) reported higher Q3 results but remained unprofitable. Net sales were $8.689 million for the quarter, up from $6.554 million a year ago, driven by prescription devices and wellness products. Gross profit was $7.470 million, offset by operating expenses of $10.354 million, resulting in a net loss of $3.405 million, or $0.40 per share. For the nine months, net sales reached $22.789 million versus $18.136 million.

Liquidity improved with cash, cash equivalents, restricted cash and marketable securities totaling $13.201 million as of September 30, 2025. Long‑term debt stood at $6.526 million after a $7.5 million Avenue term loan bearing at least 12.50% interest, with up to $2.5 million convertible at $8.4625 per share and a potential additional $4.5 million Tranche 2. Stockholders’ equity shifted to a deficit of $1.073 million. Sales to the U.S. Department of Veterans Affairs accounted for 69.9% of Q3 net sales. The company also maintains a $20 million ATM program and a $100 million shelf.

electroCore, Inc. furnished an 8-K stating it issued a press release announcing financial results for the quarter ended September 30, 2025 and providing updated guidance for the fourth quarter and full year 2025.

The press release is attached as Exhibit 99.1. The company notes that, except for information relating to Adjusted EBITDA net loss from operations and its reconciliation to GAAP, the information in Items 2.02 and 9.01, including Exhibit 99.1, is furnished and not deemed filed under the Exchange Act.

electroCore, Inc. filed a resale prospectus registering up to 762,508 shares of common stock for offer and sale by selling stockholders. The registration covers 295,420 Conversion Shares issuable upon conversion of up to $2,500,000 of loan principal at $8.4625 per share, 106,351 Private Placement Shares issued to Avenue in connection with the loan, and 360,737 Private Shares issued in October 2025 private placements. The company is not selling any securities in this prospectus and will not receive proceeds from any resale.

The shares stem from an August 4, 2025 Loan and Security Agreement providing up to $12.0 million in term loans (including a funded $7.5 million tranche) maturing on August 1, 2029, with a minimum interest rate of 12.50% and a conversion right for Avenue tied to the Conversion Shares. Including representative holders, this registration lists, among others, Avenue Venture Opportunities Fund II, L.P. 401,771 and Dentons US LLP 272,108. Shares outstanding were 7,995,903 as of October 2, 2025.

electroCore (ECOR) filed a resale registration covering up to 762,508 shares of common stock. The prospectus permits selling stockholders to resell shares from time to time using various methods at fixed, market, or negotiated prices. The company is not selling any securities in this offering and will not receive proceeds from stockholder sales.

The registered shares include 295,420 Conversion Shares issuable upon conversion of up to $2,500,000 of loan principal at a conversion price of $8.4625 per share, 106,351 Private Placement Shares issued to Avenue in connection with a loan agreement, and 360,737 Private Shares issued in October 2025 private placements at $5.145 per share. The Private Shares were issued in exchange for approximately $1.856 million of legal services. electroCore will bear registration expenses; selling holders will bear any selling commissions.

Common stock trades on Nasdaq as ECOR; the closing price was $5.12 per share on October 2, 2025. Shares outstanding were 7,995,903 as of October 2, 2025.

electroCore, Inc. filed a Form D as a new notice reporting a private securities offering under Rule 506(b). The issuer is a Delaware corporation headquartered in Rockaway, New Jersey. The filing indicates an indefinite offering with $0 sold to date and 0 investors so far. The filing discloses an inducement award: on September 10, 2025 Andy Brown was granted 10,000 restricted stock units (RSUs) outside existing plans under Nasdaq Listing Rule 5635(c)(4). The minimum investment is listed as $0, there are no sales commissions or finders fees reported, and the Form D was signed by CFO Joshua S. Lev on September 16, 2025. The company classified its industry as Other Health Care and identified issuer size as over $100,000,000.

Hilve Holdings Limited and Mikhail Stiskin disclosed beneficial ownership of 432,000 shares of electroCore, Inc. common stock, representing 5.7% of the outstanding shares based on 7,583,445 shares outstanding as of August 5, 2025. Hilve Holdings, a Cyprus company, holds the shares directly and has sole voting and dispositive power over them. Mr. Stiskin, an Israeli citizen and sole shareholder of Hilve Holdings, may be deemed the beneficial owner with identical sole voting and dispositive power. The filing states the stake was not acquired to change or influence control of the issuer.

electroCore, Inc. director Patricia Wilber received an annual award of 19,011 restricted stock units (RSUs) on 09/02/2025 that vest in 12 equal monthly installments from the grant date, but will vest in full earlier if the company holds its next annual meeting or upon a change of control, provided she remains in continuous service.

Following this grant, Ms. Wilber beneficially owns 72,325 shares, which includes 16,583 shares that vested from prior RSU grants and were previously reported. The Form 4 was filed by one reporting person and signed by an attorney-in-fact on 09/04/2025.